Bristol-Myers Squibb

Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg
Thu, 03/14/13 - 11:15 am
pancreatic cancer
diabetes
Merck
Januvia
Bristol-Myers Squibb
Byetta
Novo Nordisk
Victoza
Overseas Tax Savings for U.S. Drugmakers Under Threat
Bloomberg
Tue, 03/12/13 - 11:28 am
Pfizer
Merck
JNJ
Bristol-Myers Squibb
taxes
Puma Biotechnology Priced Like Takeover Target: Real M&A
Bloomberg
Tue, 03/12/13 - 11:26 am
Puma Biotechnology
M&A
AstraZeneca
Bristol-Myers Squibb
Takeda
Celgene
GSK
DOJ Investigating Sanofi Over Plavix Disclosure
Motley Fool
Tue, 03/12/13 - 11:25 am
Sanofi
DOJ
Plavix
Bristol-Myers Squibb
Is Opko Still A Buy As Frost Continues To Purchase Shares?
Seeking Alpha
Mon, 03/11/13 - 10:44 am
OPKO Health
Bristol-Myers Squibb
RXi Pharmaceuticals
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 03/9/13 - 12:45 pm
Repros Therapeutics
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Bristol-Myers Should Concentrate On Getting Better, Not Bigger
Seeking Alpha
Fri, 03/8/13 - 11:04 am
Bristol-Myers Squibb
R&D
Bristol-Myers Squibb's Major Patent Expirations Weigh On Its Outlook
Seeking Alpha
Wed, 03/6/13 - 09:58 am
Bristol-Myers Squibb
patents
Taking A Close Look At Bristol-Myers' Dividend
Seeking Alpha
Wed, 03/6/13 - 09:55 am
Bristol-Myers Squibb
Bristol-Myers might just make a big deal, WSJ says
Fierce Pharma
Tue, 03/5/13 - 12:01 pm
Bristol-Myers Squibb
M&A
Biogen Idec
Shire
Who's the Frailest Big Pharma of All?
Motley Fool
Sat, 03/2/13 - 04:08 pm
Bristol-Myers Squibb
AstraZeneca
Pfizer
Eli Lilly
Sanofi
How Serious Is This News for Diabetes Drugmakers?
Motley Fool
Sat, 03/2/13 - 04:00 pm
pancreatitis
diabetes
type 2 diabetes
Merck
AstraZeneca
Bristol-Myers Squibb
Hepatitis C In Play for 2013?
Motley Fool
Wed, 02/27/13 - 11:24 am
hepatitis C
BMS-986094
Bristol-Myers Squibb
Gilead
Idenix
Incivek
Achillion
Vertex Pharmaceuticals
Battle of the Pharma Dividends: Bristol vs. Lilly
Motley Fool
Tue, 02/26/13 - 10:08 am
dividends
Eli Lilly
Bristol-Myers Squibb
Merck, Bristol Diabetes Drugs Linked to Pancreatitis Risk
Bloomberg
Tue, 02/26/13 - 10:04 am
Merck
diabetes
Bristol-Myers Squibb
pancreatitis
Januvia
Byetta
Aches And Pains Shouldn't Obscure Achillion's Potential
Seeking Alpha
Fri, 02/22/13 - 10:38 am
Achillion
AbbVie
JNJ
Gilead
Bristol-Myers Squibb
Stocks Could Rise For Companies Investing In Immunotherapy Treatments
Seeking Alpha
Tue, 02/19/13 - 10:12 am
immunotherapy
Celgene
Bristol-Myers Squibb
OncoSec
ONYX Pharmaceuticals
Vical
Can Johnson & Johnson Hold Its Ground in the Multiple Myeloma Market?
Motley Fool
Wed, 02/13/13 - 10:16 am
JNJ
Multiple Myeloma
Velcade
Celgene
Revlimid
AbbVie
ONYX Pharmaceuticals
Bristol-Myers Squibb
Reckitt in $482 mln deal to sell Bristol drugs in LatAm
Reuters
Tue, 02/12/13 - 10:54 am
Reckitt Benckiser
Latin America
M&A
Bristol-Myers Squibb
OTC
U.S. court invalidates patent on Bristol hepatitis B drug
Reuters
Tue, 02/12/13 - 10:46 am
Bristol-Myers Squibb
hepatitis B
Baraclude
patents

Pages